BioCentury
ARTICLE | Clinical News

Feedback Controlled Heparin System: GNSA began a Phase I trial in 12 healthy volunteers.

April 29, 1996 7:00 AM UTC

Gensia Inc. (GNSA), San Diego, Calif. Product: Feedback Controlled Heparin System Use: Adjust heparin dosing Status: GNSA began a Phase I trial in 12 healthy volunteers. The Feedback system monitors a...